SenoRx, Inc.
Employing the Latin word for breast, SenoRx's name says it all: the company develops, manufactures, and distributes biopsy systems and breast tissue markers used in the diagnosis and treatment of breast cancer. Its primary diagnostic product, EnCor, is a vacuum-assisted breast biopsy probe system with which a doctor may collect tissue samples and biopsies through a proprietary transparent tissue collection chamber. The system allows the doctor to examine the quality of the specimen mid-probe, rather than performing numerous biopsies. Other core products include Contura MLB, a radiation therapy device. SenoRx was acquired by medical device maker C.R. Bard for about $200 million in 2010.